HTLV testing of solid organ transplant donors
- PMID: 31321817
- DOI: 10.1111/ctr.13670
HTLV testing of solid organ transplant donors
Comment on
-
Human T-cell lymphotrophic virus in solid-organ transplant recipients: Guidelines from the American society of transplantation infectious diseases community of practice.Clin Transplant. 2019 Sep;33(9):e13575. doi: 10.1111/ctr.13575. Epub 2019 May 12. Clin Transplant. 2019. PMID: 31021486
References
REFERENCES
-
- Kaul D, Sharma T; on behalf of the AST ID Community of Practice. Human T-cell lymphotropic virus in solid organ transplant recipients: guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transpl. 2019:e13575. [Epub ahead of print]
-
- De Mendoza C, Caballero E, Aguilera A, et al. HTLV-1 infection and disease in Spain. AIDS. 2017;31(12):1653-1663.
-
- Toro C, Rodés B, Poveda E, Soriano V. Rapid development of subacute myelopathy in three organ transplant recipients after transmission of HTLV type I from a single donor. Transplantation. 2003;75:102-104.
-
- Moreno-Ajona D, Yuste J, Martín P, Gállego J. HTLV-1 myelopathy after renal transplant and antiviral prophylaxis: the need for screening. J Neurovirol. 2018;24:523-525.
-
- Yamauchi J, Yamano Y, Yuzawa K. Risk of human T-cell leukemia virus type 1 infection in kidney transplantation. N Engl J Med. 2019;380:296-298.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
